Fuelled by innovation, the outlook for the biotech sector remains positive and should be viewed separately from the macro environment, says Peter Hughes.
Metals cut on growth revisions
Reports of no planned forecast
Financial crises loom in emerging markets
Unprecedented hike of 0.75%